▁Pat 10.375
ients 2.453125
▁with 5.06640625
▁r 7.8125
he 0.96728515625
um 2.32421875
ato 4.97265625
id 1.42578125
▁ar 2.390625
th 0.56884765625
rit 2.3203125
is 2.1015625
▁of 5.015625
▁the 2.169921875
▁hand 4.4453125
▁experience 9.8359375
▁significant 9.3515625
▁challeng 8.1953125
es 1.7841796875
▁in 4.14453125
▁maintain 9.8125
ing 0.73583984375
▁an 4.28125
▁exercise 6.23828125
▁and 3.7734375
▁spl 11.8046875
int 3.37890625
ing 2.5546875
▁regime 8.625
▁as 4.69140625
▁pres 8.65625
cribed 1.1494140625
▁by 2.849609375
▁occup 7.578125
ational 0.7333984375
▁ther 1.6884765625
ap 0.84716796875
ists 1.140625
. 2.107421875
▁A 4.21875
▁natural 7.41015625
istic 3.419921875
, 3.55078125
▁phenomen 5.671875
ological 0.38671875
▁research 4.1640625
▁approach 2.50390625
▁can 7.87890625
▁be 0.7666015625
▁used 1.11328125
▁to 0.395263671875
▁explore 1.94921875
▁the 0.826171875
▁lived 1.673828125
▁experiences 0.4794921875
▁of 0.16015625
▁these 3.607421875
▁patients 2.681640625
▁and 1.8759765625
▁understand 6.46875
▁the 1.078125
▁factors 3.224609375
▁influen 2.580078125
cing 0.0002593994140625
▁their 0.66845703125
▁ad 4.4375
her 0.13525390625
ence 0.00450897216796875
▁to 0.49365234375
▁treatment 2.283203125
. 0.7119140625
▁ 4.90625
<0x0A> 6.2109375
<0x0A> 2.369140625
To 4.5546875
▁explore 2.791015625
▁these 2.744140625
▁questions 3.44921875
, 0.4697265625
▁semi 4.65234375
- 0.0743408203125
struct 0.00531768798828125
ured 0.00023066997528076172
▁inter 0.33935546875
views 0.0009975433349609375
▁with 2.220703125
▁participants 4.44140625
▁can 6.03125
▁be 0.1058349609375
▁conducted 1.2646484375
▁to 2.02734375
▁gain 2.056640625
▁ins 2.9375
ights 0.0007658004760742188
▁into 0.34423828125
▁their 1.15625
▁experiences 1.158203125
▁with 1.9208984375
▁the 2.392578125
▁treatment 1.6943359375
▁regime 3.548828125
▁from 6.1953125
▁their 1.837890625
▁own 1.7216796875
▁pers 0.77392578125
pect 0.0018301010131835938
ives 5.793571472167969e-05
. 0.23095703125
▁Open 7.87109375
- 0.3271484375
ended 0.018646240234375
▁questions 0.77099609375
▁will 3.544921875
▁allow 2.8671875
▁participants 1.6533203125
▁to 0.05242919921875
▁describe 2.712890625
▁their 0.75732421875
▁experiences 0.958984375
▁in 1.8291015625
▁their 2.36328125
▁own 0.01477813720703125
▁words 0.0831298828125
. 0.857421875
▁Part 3.005859375
icip 0.006763458251953125
ant 3.580078125
▁di 6.66015625
aries 0.021881103515625
▁kept 9.078125
▁by 3.494140625
▁the 1.361328125
▁patients 1.8740234375
▁over 3.142578125
▁a 1.2080078125
▁period 0.466552734375
▁of 0.0197296142578125
▁time 0.54443359375
▁will 1.6328125
▁provide 2.373046875
▁a 1.9013671875
▁longitud 3.802734375
inal 0.0028896331787109375
▁record 2.39453125
▁of 0.12225341796875
▁their 0.994140625
▁experiences 0.93994140625
, 3.193359375
▁challeng 6.33984375
es 0.01259613037109375
, 0.80517578125
▁feelings 5.80859375
, 0.71044921875
▁and 0.465576171875
▁re 2.87109375
actions 0.072509765625
▁to 0.75244140625
▁the 0.78857421875
▁treatment 0.3701171875
. 1.5849609375
▁Research 6.46484375
er 2.609375
▁di 2.447265625
aries 0.027557373046875
▁kept 2.85546875
▁by 1.55078125
▁the 0.2047119140625
▁interview 5.28515625
ers 0.08203125
▁will 0.6875
▁capture 3.67578125
▁their 2.24609375
▁own 1.251953125
▁ref 2.728515625
lections 0.011810302734375
▁and 1.2177734375
▁ins 2.72265625
ights 0.00014507770538330078
▁gained 3.7109375
▁through 2.876953125
▁the 0.537109375
▁process 1.7421875
. 0.53466796875
▁These 2.703125
▁multiple 6.7578125
▁data 2.505859375
▁sources 0.35107421875
▁will 0.58984375
▁enable 2.873046875
▁tri 6.98046875
ang 0.0006151199340820312
ulation 0.03753662109375
▁to 3.05859375
▁verify 5.25390625
▁and 1.630859375
▁en 6.0703125
rich 0.0045928955078125
▁the 0.5439453125
▁find 1.1123046875
ings 7.748603820800781e-06
. 0.67138671875
<0x0A> 0.97998046875
<0x0A> 0.047821044921875
S 4.76953125
ever 2.580078125
al 0.002300262451171875
▁eth 4.421875
ical 0.09881591796875
▁consider 0.5869140625
ations 1.8477439880371094e-05
▁must 1.7568359375
▁be 0.0252838134765625
▁addressed 1.8154296875
. 2.498046875
▁Inform 4.953125
ed 0.0124969482421875
▁consent 0.1195068359375
▁must 1.1474609375
▁be 0.01800537109375
▁obtained 0.2001953125
▁from 0.28173828125
▁all 1.7138671875
▁participants 0.217041015625
▁after 6.36328125
▁explaining 2.841796875
▁the 0.1861572265625
▁research 2.541015625
▁object 2.279296875
ives 0.00021064281463623047
▁and 0.69873046875
▁what 5.30859375
▁their 4.39453125
▁participation 0.2239990234375
▁will 1.314453125
▁involve 1.357421875
. 0.114013671875
▁Part 2.181640625
icip 0.0032634735107421875
ants 0.0435791015625
▁must 0.81689453125
▁understand 1.884765625
▁that 0.51123046875
▁their 1.4208984375
▁participation 1.3564453125
▁is 0.92333984375
▁volunt 0.4501953125
ary 0.00579833984375
▁and 0.414794921875
▁they 2.392578125
▁can 1.47265625
▁withdraw 0.429443359375
▁at 0.5380859375
▁any 0.005687713623046875
▁time 0.1357421875
. 0.482177734375
▁Conf 4.12109375
ident 0.0115966796875
ial 6.699562072753906e-05
ity 0.00955963134765625
▁must 0.71484375
▁be 0.090087890625
▁ens 2.212890625
ured 1.9788742065429688e-05
▁by 2.21484375
▁removing 6.17578125
▁any 2.333984375
▁ident 0.327880859375
ifying 0.382568359375
▁information 0.447509765625
▁from 0.9033203125
▁the 0.6376953125
▁data 1.0576171875
▁and 2.16796875
▁secure 5.99609375
ly 0.54833984375
▁storing 0.29150390625
▁all 2.255859375
▁records 4.15234375
. 0.65234375
▁The 2.20703125
▁potential 5.64453125
▁benefits 1.9873046875
▁of 0.81982421875
▁gain 6.25390625
ing 0.004322052001953125
▁valuable 3.849609375
▁ins 0.765625
ights 7.522106170654297e-05
▁into 0.48681640625
▁patients 2.849609375
’ 27.78125
▁experiences 0.70751953125
▁and 2.296875
▁ident 3.796875
ifying 0.06744384765625
▁strateg 4.7265625
ies 0.0023021697998046875
▁to 0.7939453125
▁improve 0.626953125
▁ad 1.3447265625
her 0.0010280609130859375
ence 0.0006966590881347656
▁to 0.9853515625
▁treatment 0.2052001953125
▁must 0.89990234375
▁be 0.53759765625
▁we 0.496826171875
ighed 0.00021946430206298828
▁against 0.047454833984375
▁any 2.529296875
▁dis 4.265625
com 1.1943359375
fort 0.00112152099609375
▁to 4.96484375
▁participants 0.77197265625
. 0.9091796875
▁The 2.390625
▁research 2.10546875
▁must 4.08984375
▁be 0.697265625
▁approved 3.841796875
▁by 0.07769775390625
▁an 1.65234375
▁eth 0.8125
ics 0.05633544921875
▁review 2.7421875
▁board 0.55810546875
. 1.7138671875
<0x0A> 0.69384765625
<0x0A> 0.0184326171875
To 4.50390625
▁fully 5.67578125
▁understand 0.69189453125
▁patients 2.9375
’ 24.125
▁experiences 0.61669921875
, 1.537109375
▁a 2.36328125
▁natural 2.93359375
istic 0.007778167724609375
▁inqu 6.23828125
iry 0.0005636215209960938
▁with 4.98046875
▁a 2.095703125
▁phenomen 0.227294921875
ological 0.041473388671875
▁emphas 5.69140625
is 0.000759124755859375
▁on 3.40234375
▁subject 5.94140625
ive 0.167236328125
▁experiences 1.7216796875
▁and 1.92578125
▁meaning 3.05078125
▁making 1.1962890625
▁is 1.32421875
▁appropriate 3.3984375
. 0.1727294921875
▁Multiple 6.53125
▁qual 3.708984375
itative 0.00386810302734375
▁data 1.875
▁collection 2.853515625
▁methods 0.744140625
▁will 1.3203125
▁be 0.327392578125
▁used 0.496826171875
▁to 0.486572265625
▁gather 3.232421875
▁rich 2.86328125
▁descri 2.03125
ptions 0.00010859966278076172
▁of 0.25390625
▁the 1.0947265625
▁participants 2.04296875
’ 24.3125
▁lived 2.39453125
▁experiences 0.07452392578125
▁of 2.322265625
▁cop 7.13671875
ing 0.006511688232421875
▁with 0.1746826171875
▁the 1.65234375
▁treatment 0.599609375
▁regime 0.48583984375
▁for 5.30078125
▁r 2.513671875
he 0.0018472671508789062
um 0.000484466552734375
ato 0.051361083984375
id 0.0004208087921142578
▁ar 0.0196075439453125
th 0.00012683868408203125
rit 0.0005927085876464844
is 0.000640869140625
▁in 4.4140625
▁their 2.556640625
▁own 0.35595703125
▁words 0.049072265625
. 0.119873046875
▁By 4.96484375
▁expl 3.357421875
oring 0.0014352798461914062
▁both 4.8515625
▁positive 3.85546875
▁experiences 4.59375
▁that 5.61328125
▁encou 5.6875
rage 5.793571472167969e-05
▁ad 0.82666015625
her 0.0011835098266601562
ence 0.002307891845703125
▁as 2.900390625
▁well 0.007808685302734375
▁as 0.005451202392578125
▁challeng 1.419921875
es 0.0955810546875
▁that 1.45703125
▁disc 2.70703125
ou 1.7404556274414062e-05
rage 0.0227203369140625
▁ad 0.51806640625
her 0.0006036758422851562
ence 0.0022106170654296875
, 0.1719970703125
▁the 1.3310546875
▁research 1.3212890625
▁a 3.505859375
ims 0.0005946159362792969
▁to 0.042694091796875
▁identify 2.259765625
▁factors 2.1015625
▁influen 1.2734375
cing 1.1324882507324219e-05
▁patients 2.0
’ 20.84375
▁comp 5.9140625
liance 0.002857208251953125
▁with 0.6884765625
▁treatment 0.4267578125
▁to 4.49609375
▁inform 2.197265625
▁improved 4.14453125
▁practice 4.15625
. 0.83740234375
